In addition, a high co-occurrence of alterations in subunits of INO80 and mTORC1 was observed in PDAC and other cancers, suggesting that disruption of these pathways might contribute to the metabolic dysregulation involved in tumorigenesis [71]. This evidence concerns the gene INO80 and cancer.